Replication organelles of hepatitis C virus and SARS-CoV-2: Surprising similarities and avenues for broad-spectrum antivirals

被引:0
|
作者
Roingeard, Philippe [1 ,2 ,3 ,4 ]
机构
[1] Univ Tours, Inserm, MAVIVH, U1259, 10 Blvd Tonnelle, F-37032 Tours, France
[2] Univ Tours, Plateforme IBiSA Microscopie Elect, 10 Blvd Tonnelle, F-37032 Tours, France
[3] CHU Tours, 10 Blvd Tonnelle, F-37032 Tours, France
[4] Inserm, Fac Med Tours, MAVIVH, U1259, 10 Blvd Tonnelle, F-37032 Tours, France
来源
关键词
COVID-19; Severe acute respiratory syndrome; Hepatitis C; RNA virus infections; Virus replication; Antiviral agents; CORONAVIRUS REPLICATION; ENDOPLASMIC-RETICULUM; PROTEINS; RNA;
D O I
10.1016/j.banm.2023.10.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Positive single -strand RNA (+RNA) viruses can remodel host cell membranes to induce replication organelles isolating the replication of their genome from cellular innate immunity mechanisms. Some of these viruses, including the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), induce double-membrane vesicles (DMV) to behave as replication organelles. As for the hepatitis C virus (HCV), pores crossing both membranes of SARS-CoV-2-induced DMV have been identified. These pores likely allow the supply of metabolites essential for viral replication within the DMV, and allow the export of the newly synthesized viral RNA to form the genome of the neo-synthesized virions. However, it remains unknown whether DMV with open pores can coexist with fully sealed DMV allowing the storage of large amounts of viral RNA, as seen for the HCV model. Interestingly, recent studies have revealed many similarities in the mechanisms of DMV biogenesis between these two phylogenetically distant viruses. Understanding the mechanisms of DMV formation and function will be essential for the development of new broad-spectrum antiviral approaches, able to inhibit DMV-inducing viruses from different families. (c) 2023 l'Academie nationale de medecine. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 50 条
  • [1] Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses
    Grazia Martina, Maria
    Vicenti, Ilaria
    Bauer, Lisa
    Crespan, Emmanuele
    Rango, Enrico
    Boccuto, Adele
    Olivieri, Noemi
    Incerti, Matteo
    Zwaagstra, Marleen
    Allodi, Marika
    Bertoni, Simona
    Dreassi, Elena
    Zazzi, Maurizio
    van Kuppeveld, Frank J. M.
    Maga, Giovanni
    Radi, Marco
    CHEMMEDCHEM, 2021, 16 (23) : 3548 - 3552
  • [2] Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2
    Gross, Rudiger
    Dias Loiola, Livia Mesquita
    Issmail, Leila
    Uhlig, Nadja
    Eberlein, Valentina
    Conzelmann, Carina
    Olari, Lia-Raluca
    Rauch, Lena
    Lawrenz, Jan
    Weil, Tatjana
    Mueller, Janis A.
    Cardoso, Mateus Borba
    Gilg, Andrea
    Larsson, Olivia
    Hoeglund, Urban
    Palsson, Sandra Axberg
    Tvilum, Anna Selch
    Lovschall, Kaja Borup
    Kristensen, Maria M.
    Spetz, Anna-Lena
    Hontonnou, Fortune
    Galloux, Marie
    Grunwald, Thomas
    Zelikin, Alexander N.
    Munch, Jan
    ADVANCED SCIENCE, 2022, 9 (20)
  • [3] A Broad-Spectrum Antimicrobial and Antiviral Membrane Inactivates SARS-CoV-2 in Minutes
    Liu, Qingsheng
    Zhang, Yidan
    Liu, Wanjun
    Wang, Long-Hai
    Choi, Young W.
    Fulton, Megan
    Fuchs, Stephanie
    Shariati, Kaavian
    Qiao, Mingyu
    Bernat, Victorien
    Ma, Minglin
    ADVANCED FUNCTIONAL MATERIALS, 2021, 31 (47)
  • [4] A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein
    Thijssen, Vito
    Hurdiss, Daniel L.
    Debski-Antoniak, Oliver J.
    Spence, Matthew A.
    Franck, Charlotte
    Norman, Alexander
    Aggarwal, Anupriya
    Mokiem, Nadia J.
    van Dongen, David A. A.
    Vermeir, Stein W.
    Liu, Minglong
    Li, Wentao
    Chatziandreou, Marianthi
    Donselaar, Tim
    Du, Wenjuan
    Drulyte, Ieva
    Bosch, Berend-Jan
    Snijder, Joost
    Turville, Stuart G.
    Payne, Richard J.
    Jackson, Colin J.
    van Kuppeveld, Frank J. M.
    Jongkees, Seino A. K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (26)
  • [5] Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo
    Narayan, Rohan
    Sharma, Mansi
    Yadav, Rajesh
    Biji, Abhijith
    Khatun, Oyahida
    Kaur, Sumandeep
    Kanojia, Aditi
    Joy, Christy Margrat
    Rajmani, Raju
    Sharma, Pallavi Raj
    Jeyasankar, Sharumathi
    Rani, Priya
    Shandil, Radha Krishan
    Narayanan, Shridhar
    Rao, Durga Chilakalapudi
    Satchidanandam, Vijaya
    Das, Saumitra
    Agarwal, Rachit
    Tripathi, Shashank
    CELL REPORTS MEDICINE, 2023, 4 (08)
  • [6] From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
    Ma, Cuiqing
    Su, Shan
    Wang, Jiachao
    Wei, Lin
    Du, Lanying
    Jiang, Shibo
    MICROBES AND INFECTION, 2020, 22 (6-7) : 245 - 253
  • [7] JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis
    Son, Juhee
    Huang, Shimeng
    Zeng, Qiru
    Bricker, Traci L.
    Case, James Brett
    Zhou, Jinzhu
    Zang, Ruochen
    Liu, Zhuoming
    Chang, Xinjian
    Darling, Tamarand L.
    Xu, Jian
    Harastani, Houda H.
    Chen, Lu
    Gomez Castro, Maria Florencia
    Zhao, Yongxiang
    Kohio, Hinissan P.
    Hou, Gaopeng
    Fan, Baochao
    Niu, Beibei
    Guo, Rongli
    Rothlauf, Paul W.
    Bailey, Adam L.
    Wang, Xin
    Shi, Pei-Yong
    Martinez, Elisabeth D.
    Brody, Steven L.
    Whelan, Sean P. J.
    Diamond, Michael S.
    Boon, Adrianus C. M.
    Li, Bin
    Ding, Siyuan
    MBIO, 2022, 13 (01):
  • [8] Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors
    Weidenbacher, Payton A. -B.
    Waltari, Eric
    de los Rios Kobara, Izumi
    Bell, Benjamin N.
    Morris, Mary Kate
    Cheng, Ya-Chen
    Hanson, Carl
    Pak, John E.
    Kim, Peter S.
    NATURE CHEMICAL BIOLOGY, 2022, 18 (11) : 1270 - +
  • [9] Engineering mRNA vaccine with broad-spectrum protection against SARS-cov-2 variants
    Du, Shuang
    Yang, Liu
    Chen, Xingguang
    Chen, Yonghao
    Weng, Liang
    Huang, Hui
    Pang, Silin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2025, 746
  • [10] Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization
    Zhang, Ran
    Huang, Lan
    Zhang, Xiaohan
    Yu, Yuanling
    Liang, Te
    Wang, Hongye
    Zhang, Xiaomei
    Hu, Di
    Wang, Bingwei
    Wang, Youchun
    Jiang, Junyi
    Yu, Xiaobo
    JOURNAL OF PROTEOME RESEARCH, 2024, 23 (05) : 1559 - 1570